Targeting aldehyde dehydrogenase for prostate cancer therapies.

Ma, Miao; He, Wenyou; Zhao, Keyu; Xue, Linyuan; Xia, Siyuan; Zhang, Baotong

Ma, Miao; He, Wenyou; Zhao, Keyu; Xue, Linyuan; Xia, Siyuan; Zhang, Baotong.

Afiliação

Ma M; Department of Human Cell Biology and Genetics, School of Medicine, Southern University of Science and Technology, Shenzhen, China.
He W; Department of Human Cell Biology and Genetics, School of Medicine, Southern University of Science and Technology, Shenzhen, China.
Zhao K; Department of Human Cell Biology and Genetics, School of Medicine, Southern University of Science and Technology, Shenzhen, China.
Xue L; Department of Human Cell Biology and Genetics, School of Medicine, Southern University of Science and Technology, Shenzhen, China.
Xia S; Department of Human Cell Biology and Genetics, School of Medicine, Southern University of Science and Technology, Shenzhen, China.
Zhang B; Department of Human Cell Biology and Genetics, School of Medicine, Southern University of Science and Technology, Shenzhen, China.

Front Oncol ; 12: 1006340, 2022.

Article em En | MEDLINE | ID: mdl-36300093

Palavras-chave

aldehyde dehydrogenase; cancer stem-like cells (CSCs); drug resistance; prostate cancer; signaling transduction; targeted therapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article